Pharma & Biotech

As the coronavirus era recedes into history, BioNTech faces the formidable challenge of redefining its corporate identity. The German biotech...

After an extended period of decline, the biotechnology giant Biogen is demonstrating renewed vigor. A convergence of regulatory victories and...

Rigel Pharmaceuticals shares are experiencing downward momentum following an important clinical development announcement. The biotechnology firm revealed it has enrolled...

A bold strategic decision has positioned Monopar Therapeutics at the center of investor attention. The clinical-stage biopharmaceutical company is advancing...

Investors in Valneva are navigating turbulent waters as the biotechnology firm delivers a dual announcement: significantly reduced annual projections coupled...

A federal appeals court in the United States has unanimously rejected Novo Nordisk's legal challenge against the Medicare drug price...

Sarepta Therapeutics shares continue to experience extreme volatility as promising clinical developments clash with significant safety concerns. The biotechnology firm...

The life sciences and diagnostics company Danaher confronts mounting pressure as two significant developments emerge simultaneously. Investment firm Rothschild &...

Bristol-Myers Squibb has secured a significant regulatory milestone for its Alzheimer's drug candidate BMS-986446, receiving Fast Track designation from the...

Thermo Fisher Scientific may have found the catalyst needed to jumpstart its growth trajectory with a groundbreaking medical innovation. The...